Founded in 2011, Samabriva is a biotechnology company which has developed a disruptive platform (the “RHIZOBRIVA™” platform) from plant material enabling the production of biomolecules suitable for the pharmaceutical industry, as well as the cosmetics, agrochemicals and food industries


Using this platform, Samabriva focused its internal R&D program on the development of orphan drugs for the treatment of rare diseases, with a particular attention paid to the  lysosomal storage disorders (« LSD »). Samabriva has built an independant business unit  (the “NANOBRIVA™” platform) to gather these internal R&D programs.


A greentech platform gathering the advantages of both plants and bioreactor-confined processes to produce complex molecules

NanoBriva ™

An innovative platform to develop innovative products in the rare diseases area


72 rue des Jacobins 80 000 Amiens

+33 (0) 322 092 830


For any question, please send us your message


© 2020 created by Samabriva.